单位:北京大学第三医院呼吸与危重症医学科 一、急性纤维素性机化性肺炎 注:1为肺泡腔内“纤维蛋白球”,无透明膜形成;2为肺泡腔内纤维蛋白填充,散在机化性肺炎形成;3为纤维素形成 机化性肺炎,弥漫性浸润;4为机化性肺炎,伴肺泡内纤维蛋白周围成纤维组织形成。 图1 AFOP影像学表现 注:A:两肺胸膜下大片状实变影,支气管充气征明显,此为AFOP中最为常见的影像学表现;B:类似于重症病毒性肺炎表现,纯磨玻璃密度影,无明显实变;C:主要表现为结节影,间质性改变为主,经病理证实为AFOP。 图引自:Onishi Y, Kawamura T, Higashino T, Mimura R, Tsukamoto H, Sasaki S. Clinical features of acute fibrinous and organizing pneumonia: An early histologic pattern of various acute inflammatory lung diseases[J]. PLoS One, 2021, 16(4): e0249300. 二、经支气管镜冷冻肺活检在弥漫性间质性肺疾病中的应用 三、抗前列腺癌药物与AFOP 四、总结 参考文献 [1] Cohen A J, King T E Jr, Downey G P. Rapidly progressive bronchiolitis obliterans with organizing pneumonia[J]. Am J Respir Crit Care Med, 1994, 149(6):1670-1675. [2] Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage[J]. Arch Pathol Lab Med, 2002, 126(9):1064-1070. [3] Radzikowska E, Fijolek J. Update on cryptogenic organizing pneumonia[J]. Front Med (Lausanne), 2023, 10:1146782. [4] Gomes R, Padrão E, Dabó H, et al. Acute fibrinous and organizing pneumonia: A report of 13 cases in a tertiary university hospital[J]. Medicine (Baltimore), 2016, 95(27):e4073. [5] Lee J H, Yum H K, Jamous F, et al. Diagnostic procedures and clinico-radiological findings of acute fibrinous and organizing pneumonia: a systematic review and pooled analysis[J]. Eur Radiol, 2021, 31(10):7283-7294. [6] Ussavarungsi K, Kern R M, Roden A C, et al. Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease: Retrospective Analysis of 74 Cases[J]. Chest, 2017, 151(2):400-408. [7] Hostettler K E, Tamm M, Bubendorf L, et al. Integration of transbronchial cryobiopsy into multidisciplinary board decision: a single center analysis of one hundred consecutive patients with interstitial lung disease[J]. Respir Res, 2021, 22(1):228. [8] Pajares V, Núñez-Delgado M, Bonet G, et al. Transbronchial biopsy results according to diffuse interstitial lung disease classification. Cryobiopsy versus forceps: MULTICRIO study[J]. PLoS One, 2020, 15(9):e0239114. [9] Matsui T, Umetsu R, Kato Y, et al. Adverse Event Signals of Interstitial Lung Disease in the FDA Adverse Event Reporting System (FAERS) Database and the Japanese Adverse Drug Event Report (JADER) Database[J]. Iyakuhin Johogaku, 2015, 17:145-154. [10] Kobe H, Tachikawa R, Masuno Y, et al. Apalutamide-induced severe interstitial lung disease: A report of two cases from Japan[J]. Respir Investig, 2021, 59(5):700-705.
声明: 本文仅用于学术内容的探讨和交流,不用于任何商业和推广。临床实践需根据患者的具体情况选择适宜的处理措施。 |
|
来自: 阿丘8ubc3jh408 > 《神经系统疾病》